Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera
NCT06193408
Bacterial Infections, Bacterial Infections and Mycoses
Dhaka, Bangladesh
View Trial DetailsNCT Number: NCT05829772
This project aims to fill this essential knowledge gap by assessing the impact of oral cholera vaccine mass campaigns in 2 sites (urban and rural) in DRC, described in this protocol. The evidence generated from this project will be key to develop future strategies regarding cholera vaccine use in endemic settings, including places with higher burden in terms of cholera mortality
Looking for future studies?
Notify MeAll sexes
Observational
Epicentre/Médecins Sans Frontières, Bukama, Haut-Lomami, Democratic Republic of the Congo
The project will comprise three different components:
Clinical cholera surveillance to measure cholera diseases incidence in selected African hotspots targeted by vaccination.
Serial serological surveys to measure the prevalence of recent cholera infection (within the last 12 months).
Identification and follow up of individuals with positive V. cholerae shedding (symptomatic or asymptomatic) among sero-survey participants and among household members of cholera confirmed cases.
The present protocol relates to the setup of seroprevalence surveys and the follow up of individuals with positive V. cholerae shedding identified through seroprevalence surveys, in DRC.
This protocol will allow us to assess if a large vaccination campaign reaching high coverage in cholera hotspot in Africa can allow sustained control of cholera for at least two years, by fulfilling the following specific objectives:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
Cholera-specific antibody levels will be measured in all participants for each surveys. Serial surveys will allow monitoring level of antibodies over time following the vaccination campaign
Time frame: 2 years
Time frame: 2years
Time frame: 2 years
Time frame: 2 years
Time frame: 2 years
Time frame: 2 years
Epicentre
Other
Community-based Monitoring of Cholera Antibodies' Seroprevalence, and Home Follow-up of Positive Cases, in the Context of Cholera Vaccination Campaign, Democratic Republic of the Congo
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06193408
Bacterial Infections, Bacterial Infections and Mycoses
Dhaka, Bangladesh
View Trial DetailsNCT05814042
Bacterial Infections, Bacterial Infections and Mycoses
Dhaka, Bangladesh
View Trial DetailsNCT03251495
Bacterial Infections, Bacterial Infections and Mycoses
Atlanta, Georgia, United States
View Trial DetailsNCT06929312
Bacterial Infections, Bacterial Infections and Mycoses
Lahore, Pakistan
View Trial Details